Meaghan Hancock

Herpesvirologist, miRNA researcher, woman in science
Assistant Professor at the Vaccine and Gene Therapy Institute - OHSU

[Meaghan Hancock @HancockMeaghan]

If you are interested in the latest #HIV vaccine development our most recent paper on understanding the unique immune responses and efficacy of RhCMV-based vaccine vectors is now out in Science Immunology: https://t.co/xAlZWBmEul
@SciImmunology @OHSUNews A brief tweetorial: 1/12

[Jens Bosse @bosse_lab]

Congrats to our PhD student Enrico Caragliano for one of the best thesis in the chemistry department of UHH! Amazing colab with the Brune lab at LIV!

[Vaccine & Gene Therapy Institute @VGTI_OHSU]

Congratulations to Dan Streblow Ph.D. and colleague for receiving the 2025 PMedIC Innovation award! 🎉

[Jens Bosse @bosse_lab]

Interested in a PhD in emerging viruses and viral phase separation using imaging, biophysics, structural biology, and AI? We are part of the new CRC 1648 consortium! Our PhD position starts October 1st or later. Please have a look at the job posting: https://t.co/yirkHAVtSF

[Vaccine & Gene Therapy Institute @VGTI_OHSU]

Great job to Rebecca Skalsky and team!

Read more about their findings related to the Epstein-Barr virus below.

[Vaccine & Gene Therapy Institute @VGTI_OHSU]

Great job Brandon Wilder and team! Read more about their recent findings on antimalarial drugs here:

https://t.co/hTVV38oUTw

[Rebecca Skalsky @rebecca_skalsky]

Latest from the lab— online today https://t.co/YIclrPmqJ3

[Alyson Kelvin @akelvinlab]

Congratulations to @corcoran_lab on a very deserving mid career mentor award from the Canadian virology community @CanSocVirol Nominated by her trainees illustrates the impact she has made. Jenn, you are a fantastic role model and some I aspire to be like. Can you mentor me too?

[Stern-Ginossar lab @SGinossarLab]

Now officially published @Nature . Led by the one and only @FinkelYaara.
By engineering HCMV to express sgRNA libraries directly from the viral genome, we developed VECOS (Virus Encoded CRISPR-based direct readOut System).

[Vaccine & Gene Therapy Institute @VGTI_OHSU]

Klaus Früh PhD, Scott Hansen PhD, and Louis Picker MD, have a new paper in @ScienceAdvances which shows the OHSU developed platform for cytomegalovirus-based vaccines. It shows promise as a “shield” against cancer.
Read the article here:
https://t.co/HqSpHtwEAC

[OHSU Knight Cancer Institute @OHSUKnight]

“The idea is that by throwing a type of T cell against the cancer that the cancer hasn’t seen before, it will have a harder time evading immunity.”

- Dr. Klaus Früh on an HIV vaccine showing promise for cancer prevention: https://t.co/4uFTXikzXS

#OHSUResearch

[Anna Cliffe @AnnaCliffe1]

A postdoc position is available in our lab to work on the impact of herpes simplex virus infection on the nervous system. Great opportunity to gain expertise in different neuronal models of infection and an animal model of HSV neurogenerative disease.

[Vaccine & Gene Therapy Institute @VGTI_OHSU]

Amazing work Klaus Früh and team! They developed a platform for cytomegalovirus-based vaccines, which shows promise as a “shield” against cancer.

Read more here:
https://t.co/HqSpHtwEAC

[Vaccine & Gene Therapy Institute @VGTI_OHSU]

Last week, the VGTI renamed our building in honor of our late founding director, who passed earlier this year. Dr Nelson forged VGTI into an international powerhouse in vaccine research, contributing to many profound discoveries in immunology. Our new name, The Jay Nelson Research Building, serves as a testament to his vision and legacy.

[Anna Cliffe @AnnaCliffe1]

Apply here for the lab technician post - https://t.co/bsdyS8eQhy

And here for a lab specialist job
https://t.co/v6yshNrnGX

[Anna Cliffe @AnnaCliffe1]

The Cliffe lab is hiring a lab specialist or technician. Our current technician is leaving for grad school 👏. The post is well-suited for anyone who would like a few years of experience before grad school or for someone who would like to stay in a position for longer.
Pls RT

[Kalejta Lab @KalejtaLab]

60 days until the #HerpeticLegion reactivates at #IHW2024

[Vaccine & Gene Therapy Institute @VGTI_OHSU]

VGTI is happy to share that one of our labs, using a CMV-based cancer vaccine, has just been published in Science Advances! Congrats to Dr Klaus Frueh and his team.

This paper is the result of a wonderful, collaboration between OHSU, Mt. Sinai and Vir Biotechnology. Read the full article here:
https://t.co/PCgw4ah36O

[OHSU @OHSUNews]

Dr. Brandon Wilder is focused on finding lasting, safe and effective ways to both prevent and treat malaria, which infected 249 million people and killed 608,000 worldwide in 2022. #ResearchWeek #OHSUResearch https://t.co/9C49S8VnWO

[Waggoner Lab @LabWaggoner]

CMV-based vaccines induce T cells recognizing cancer antigens via conserved MHC-E molecules @ScienceAdvances @louispicker1 #Früh
https://t.co/cCrTO0iVaw